TZXPTianjin Zhong Xin Pharmaceutical Group (Singapore)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Pharmagenesis Inc.'s parent company, the Orchid Group, has entered into a joint venture agreement with Tianjin Zhong Xin Pharmaceutical Group (TZXP.SG), one of China's leading pharmaceutical manufacturers, to form a new company for the production of PG2, a cancer therapy drug.